DAIC

NOVEMBER 18, 2024

"Given the elevated bleeding risks associated with traditional anticoagulants, particularly when combined with antiplatelet agents, abelacimab may offer a safer alternative for patients with atrial fibrillation,” said Christian T. For more information, please visit anthostherapeutics.com.

Peripheral Arterial Disease 98

Peripheral Arterial Disease Blood Clot Coronary Artery Disease General Cardiology 98

Journal of the American Heart Association

MARCH 27, 2025

Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovascular disease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovascular disease and smoking); (..)

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Coronary Artery Disease Journal

MAY 13, 2024

Objective To investigate the impact of prior coronary artery bypass grafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. The impact of the CABG SYNTAX score was also evaluated in patients with prior CABG.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Aortic valve Aortic Stenosis 40

Stroke Journal

JANUARY 30, 2025

Introduction:Catheter ablation (CA) is superior to medical therapy in the management of atrial fibrillation (AF). and more likely to have coronary artery disease, peripheral artery disease, and chronic liver disease (p < 0.05), however they had similar CHADVASC scores (3.09

Ablation 40

Ablation Strokes Stroke Peripheral Arterial Disease 40

Journal of the American Heart Association

DECEMBER 29, 2023

We identified the subset of variables most predictive of post‐HSCT cardiovascular events, defined as a composite of cardiovascular death, myocardial infarction, heart failure, stroke, atrial fibrillation or flutter, and sustained ventricular tachycardia.

Transplant 79

Transplant Peripheral Arterial Disease Coronary Artery Disease Myocardial Infarction 79

DAIC

APRIL 5, 2024

With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD).

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

Journal of the American Heart Association

MARCH 4, 2025

In the setting of arrhythmias, specific SDoHs can increase the incidence of atrial fibrillation and adversely affect major outcomes in these patients.

Cardiovascular Disease 40

Cardiovascular Disease Peripheral Arterial Disease Congenital Heart Disease Coronary Artery Disease 40